The effect of CYP1A2 gene polymorphisms on theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients

BMB Reports

Volumn 43, Issue 8, 2010, Pages 530-534

  Uslu, Ahmet ^a   Ogus, Candan ^b   Ozdemir, Tulay ^b   Bilgen, Turker ^b   Tosun, Ozgur ^b   Keser, Ibrahim ^b  

^a MEDICAL PARK HOSPITAL   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

COPD; P450(CYP)1A2; Polymorphism; Theophylline; Turkish population

Indexed keywords

EID: 77956502159     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2010.43.8.530     Document Type: Article

References (24)

1. http://www.goldcopd.org.
2. Hanania, N. A. and Donohue, J. F. (2007) Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators. Proc. Am. Thorac. Soc. 4, 526-534.
3. Tjia, J. F., Colbert, J. and Back, D. J. (1996) Theophylline metabolism in human liver microsomes: inhibition studies. J. Pharmacol. Exp. Ther. 276, 912-917.
4. Derkenne, S., Curran, C. P., Shertzer, H. G., Dalton, T. P., Dragin, N. and Nebert, D. W. (2005) Theophylline pharmacokinetics: comparison of Cyp1a1(-/-) and Cyp1a2(-/-) knockout mice, humanized hCYP1A1_1A2 knock-in mice lacking either the mouse Cyp1a1 or Cyp1a2 gene, and Cyp1(+/+) wild-type mice. Pharmacogenet. Genomics. 15, 503-511.
5. Potkin, S. G., Bera, R., Gulasekaram, B., Costa, J., Hayes, S., Jin, Y., Richmond, G., Carreon, D., Sitanggan, K. and Gerber, B. (1994) Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J. Clin. Psychiatry. 55 (Suppl B), 133-136.
6. Barnes, P. J. (2005) Theophylline in chronic obstructive pulmonary disease: new horizons. Proc. Am. Thorac. Soc. 334-339.
7. http://www.cypalleles.ki.se/cyp1a2.htm.
8. Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M. and Kamataki, T. (1999) Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem. 125, 803-808.
9. Sachse, C., Brockmöller, J., Bauer, S. and Roots, I. (1999) Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Clin. Pharmacol. 47, 445-449.
10. Aklillu, E., Carrillo, J. A., Makonnen, E., Hellman, K., Pitarque, M., Bertilsson, L. and Ingelman-Sundberg, M. (2003) Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol. Pharmacol. 64, 659-669.
11. Allorge, D., Chevalier, D., Lo-Guidice, J. M., Cauffiez, C., Suard, F., Baumann, P., Eap, C. B. and Broly, F. (2003) Identification of a novel splice-site mutation in the CYP1A2 gene. Br. J. Clin. Pharmacol. 56, 341-344.
12. Murayama, N., Soyama, A., Saito, Y., Nakajima, Y., Komamura, K., Ueno, K., Kamakura, S., Kitakaze, M., Kimura, H., Goto, Y., Saitoh, O., Katoh, M., Ohnuma, T., Kawai, M., Sugai, K., Ohtsuki, T., Suzuki, C., Minami, N., Ozawa, S. and Sawada, J. (2004) Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes. J. Pharmacol. Exp. Ther. 308, 300-306.
13. Arif, E., Vibhuti, A., Alam, P., Deepak, D., Singh, B., Athar, M. and Pasha, M. A. (2007) Association of CYP2E1 and NAT2 gene polymorphisms with chronic obstructive pulmonary disease. Clin. Chim. Acta. 382, 37-42.
14. Korytina, G. F., Akhmadishina, L. Z., Kochetova, O. V., Zagidullin, Sh. Z. and Viktorova, T. V. (2008) Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan. Mol. Biol. (Mosk) 42, 32-41.
15. Jiang, Z., Dragin, N., Jorge-Nebert, L. F., Martin, M. V., Guengerich, F. P., Aklillu, E., Ingelman-Sundberg, M., Hammons, G. J., Lyn-Cook, B. D., Kadlubar, F. F., Saldana, S. N., Sorter, M., Vinks, A. A., Nassr, N., von Richter, O., Jin, L. and Nebert, D. W. (2006) Search for an association between the human CYP1A2 genotype and CYP1A2 metabolic phenotype. Pharmacogenet. Genomics. 16, 359-367.
16. Ghotbi, R., Christensen, M., Roh, H. K., Ingelman-Sundberg, M., Aklillu, E. and Bertilsson, L. (2007) Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans. Eur. J. Clin. Pharmacol. 63, 537-546.
17. Takata, K., Saruwatari, J., Nakada, N., Nakagawa, M., Fukuda, K., Tanaka, F., Takenaka, S., Mihara, S., Marubayashi, T. and Nakagawa, K. (2006) Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy. Eur. J. Clin. Pharmacol. 62, 23-28.
18. Obase, Y., Shimoda, T., Kawano, T., Saeki, S., Tomari, S. Y., Mitsuta-Izaki, K., Matsuse, H., Kinoshita, M. and Kohno, S. (2003) Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin. Pharmacol. Ther. 73, 468-474.
19. Skarke, C., Kirchhof, A., Geisslinger, G. and Lötsch, J. (2005) Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing. Eur. J. Clin Pharmacol. 61, 887-892.
20. Soyama, A., Saito, Y., Hanioka, N., Maekawa, K., Komamura, K., Kamakura, S., Kitakaze, M., Tomoike, H., Ueno, K., Goto, Y., Kimura, H., Katoh, M., Sugai, K., Saitoh, O., Kawai, M., Ohnuma, T., Ohtsuki, T., Suzuki, C., Minami, N., Kamatani, N., Ozawa, S. and Sawada, J. (2005) Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population. Drug. Metab. Pharmacokinet. 20, 24-33.
21. Bernauer, U., Heinrich-Hirsch, B., Tönnies, M., Peter-Matthias, W. and Gundert-Remy, U. (2006) Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination. Toxicol. Lett. 164, 278-288.
22. Fukami, T., Nakajima, M., Sakai, H., Katoh, M. and Yokoi, T. (2007) CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline. Drug Metab. Dispos. 35, 335-339.
23. Zhang, Z. Y. and Kaminsky, L. S. (1995) Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation. Biochem. Pharmacol. 50, 205-211.
24. Chida, M., Yokoi, T., Fukui, T., Kinoshita, M., Yokota, J. and Kamataki, T. (1999) Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn. J. Cancer. Res. 90, 899-902.